Details of the Drug Reposition

General Information of This Drug (ID: DMQJBUK)

• Drug Name: CD19-targeting CAR T cells (DMQJBUK)
• Drug Type: CAR T Cell Therapy

Information on Drug Reposition of This Drug

2 Phase 2 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
leukaemia	DISS7D1V	2A60-2B33	Phase 2	[1]
B-cell lymphoma	DISIH1YQ	2A86	Phase 2	[1]

References

• [1] ClinicalTrials.gov (NCT02132624) CD19-targeting 3rd Generation CAR T Cells for Refractory B Cell Malignancy - a Phase I/IIa Trial.